Published in:
Open Access
01-12-2014 | Oral presentation
Managed entry agreements
Authors:
Luisa AA Muscolo, Claudia Bernardini, Paolo D Siviero, Simona Montilla, Luca Pani
Published in:
Orphanet Journal of Rare Diseases
|
Special Issue 1/2014
Login to get access
Excerpt
New scientific progress in the “precision medicines” direction and a better diagnosis of rare diseases have led Regulators and Payers to focus their vigilance towards the real life setting. Although Regulators and Payers are taking into consideration patient pressures for rapid access to treatment, nevertheless they must balance the difficulties of taking significant decision coping with uncertainties when deciding on pricing and reimbursement processes. …